RxFunction Awarded Defense Contract for R&D Project
“Although we continue our focus on the Walkasins neuroprosthesis technology for individuals with sensory peripheral neuropathy who have gait and balance problems, this Department of Defense contract award will allow us to expand our technology platform towards use in enhanced rehabilitation for individuals with lower limb trauma and/or loss. Furthermore, the project involves close collaboration with a major prosthesis company, which could further leverage strategic opportunities for us.” -Lars Oddsson
Lars Oddsson, PhD, is a scientist and professor. He is also Co-Founder and Chief Technology Officer of RxFunction, Inc., and co-inventor of Walkasins, an RxFunction product to help patients with challenges with balance due to peripheral nerve damage.